Astellas Pharma
4503.T
$9.58
Share price
1.02%
Change (1 day)
-36.13%
Change (1 year)
Categories
Operating Margin for Astellas Pharma (4503.T)
Operating Margin as of April 2024 (TTM): 9.75%
According to Astellas Pharma's latest financial reports and stock price the company's current Operating Margin is 9.75%. At the end of 2022 the company had an Operating Margin of 12.49%.
Operating Margin history for Astellas Pharma from 2009 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 12.49% | 5.66% |
| 2021 | 11.82% | -38.1% |
| 2020 | 19.09% | -0.35% |
| 2019 | 19.16% | 13.29% |
| 2018 | 16.91% | -21.83% |
| 2017 | 21.63% | 12.74% |
| 2016 | 19.19% | 24.16% |
| 2015 | 15.45% | 42.49% |
| 2014 | 10.85% | -12.71% |
| 2013 | 12.42% | -5.31% |
| 2012 | 13.12% | 5.03% |
| 2011 | 12.49% | -47.63% |
| 2010 | 23.86% | -21.43% |
| 2009 | 30.37% | 9.86% |
| 2008 | 27.64% | 19.97% |
| 2007 | 23.04% | 13.53% |
| 2006 | 20.29% | 27.06% |
| 2005 | 15.97% | -21.34% |
| 2004 | 20.30% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.